Biotech startups in Canada
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| Specific Biologics | Toronto | Series A | $35.0M | 2026-11-02 |
| Muse | Toronto | Series C | $9.5M | 2022-08-11 |
| BenchSci | Toronto | Series D | $69.6M | 2023-05-25 |
| ODAIA | Toronto | Series B | $25.0M | 2023-05-01 |
| Kainova Therapeutics | Montréal | Series B | $23.5M | 2026-02-09 |
| Altis Labs | Toronto | Series A | $25.0M | 2026-09-17 |
| Reunion Neuroscience | Toronto | Series A | $133.0M | 2025-09-16 |
| Variational AI | Vancouver | Seed | $5.5M | 2025-02-20 |
8 rows of the CSV in 5 of its 18 columns.
- The 285 biotech startups in Canada have raised $2.5B in total.
- 28 of them closed their most recent round in the last 12 months, $161.2M combined.
- The largest of those rounds is Specific Biologics' $35.0M Series A, dated November 2026.
- The most recent is Thryv Therapeutics' $21.5M Series B on 3 November 2026.
- Creative Destruction Lab is an investor in 11 of them, more than any other fund.
- Health care is the most common other sector, with 215 companies (75%).
- 26% were founded in 2020 or later; the median founding year is 2016.
- The most common team size is 1 to 10 employees (59% of companies with a recorded size).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
21 of 285| Company | What they do | Sector | City | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| Specific Biologics | Specific Biologics develops gene editing technologies to treat diseases at the genetic level inside the body. | Biotech | Toronto | Series A | $35.0M | 2026-11-02 | $36.3M | Creative Destruction Lab, Lumira Ventures, adMare Bio Innovations | 1 to 10 | 2017 |
| Altis Labs | Altis Labs uses AI endpoints to speed clinical trials so new treatments reach patients sooner. | Artificial intelligence | Toronto | Series A | $25.0M | 2026-09-17 | $31.0M | Creative Destruction Lab, Debiopharm Innovation Fund, Benchstrength | 11 to 50 | 2019 |
| BryoSphere | BryoSphere manufactures specialty chemicals using moss plants and biotechnology methods. | Biotech | Burnaby | Angel | $29K | 2026-09-08 | $29K | SOSV, SOSV SF & NY (Fka IndieBio) | 1 to 10 | 2022 |
| 3D BioFibR | 3D BioFibR manufactures biopolymer fibers, yarns, and scaffolds for medical devices and regenerative medicine. | Biotech | Halifax | Seed | $100K | 2026-07-10 | $8.5M | Creative Destruction Lab, Innovacorp, Globalive +2 | 11 to 50 | 2020 |
| Opalia | Opalia develops cell-based food technology for producing animal-free dairy. | Biotech | Montréal | Seed | $2.3M | 2026-04-28 | $3.9M | Business Development Bank of Canada, Investissement Quebec, Cycle Momentum +2 | 1 to 10 | 2020 |
| Future Fertility | Future Fertility provides artificial intelligence tools for reproductive medicine. | Artificial intelligence | Toronto | Series A | $4.1M | 2026-04-23 | $4.1M | M Ventures, Whitecap Venture Partners | 11 to 50 | 2018 |
| Kainova Therapeutics | Kainova Therapeutics develops therapies that modulate GPCRs to treat immuno-oncology and inflammatory conditions. | Biotech | Montréal | Series B | $23.5M | 2026-02-09 | $123.6M | Bpifrance, Sofinnova Partners, Andera Partners +1 | 11 to 50 | 2001 |
| Syngli | Syngli builds an interactive tutoring system that supports both teaching and learning. | Artificial intelligence | Kitchener | Seed | $24K | 2025-09-30 | $726K | Accelerator Centre, Communitech | 1 to 10 | 2014 |
| Reunion Neuroscience | Reunion Neuroscience develops therapeutic treatments for underserved mental health conditions. | Biotech | Toronto | Series A | $133.0M | 2025-09-16 | $133.0M | Novo Holdings, Mitsui Global Investment, MPM Capital +2 | 1 to 10 | 2019 |
| Atorvia Health Technologies | Atorvia Health Technologies is a preclinical biotech firm developing a renal franchise to prevent and treat kidney failure. | Biotech | Mississauga | Pre-seed | $35K | 2025-03-30 | $56K | FedDev | 1 to 10 | 2021 |
| Variational AI | Variational AI applies generative AI to drug discovery. | Artificial intelligence | Vancouver | Seed | $5.5M | 2025-02-20 | $9.2M | Alliance of Angels, Flying Fish Partners, A&E Investments | 11 to 50 | 2019 |
| Borealis Biosciences | Borealis Biosciences develops RNA medicines. | Biotech | Vancouver | Series A | $30.0M | 2024-12-19 | $180.0M | Versant Ventures, Westlake Village BioPartners | 11 to 50 | 2024 |
| Genuine Taste | Genuine Taste produces real animal fat without harming animals to improve alternative meat. | Biotech | Toronto | Pre-seed | $69K | 2024-12-18 | Antler, Big Idea Ventures, Cycle Momentum +1 | 1 to 10 | 2022 | |
| Ceragen | Ceragen is a biotechnology company that boosts crop yields through plant microbiome engineering. | Biotech | Kitchener | Seed | $2.0M | 2024-07-16 | SOSV, SOSV SF & NY (Fka IndieBio), 1517 Fund +1 | 1 to 10 | 2021 | |
| Saguaro Technologies | Saguaro Technologies develops new drug discovery technologies to fight human disease. | Biotech | Quebec | Seed | $3.0M | 2024-06-04 | $4.1M | Anges Quebec, Investissement Quebec, AQC Capital | 1 to 10 | 2020 |
| BenchSci | BenchSci uses machine learning and artificial intelligence to speed up biomedical discovery. | Artificial intelligence | Toronto | Series D | $69.6M | 2023-05-25 | Creative Destruction Lab, Inovia Capital, Gradient +2 | 251 to 500 | 2015 | |
| ODAIA | ODAIA provides an AI-powered customer data platform for the life sciences industry. | Artificial intelligence | Toronto | Series B | $25.0M | 2023-05-01 | $43.4M | Alumni Ventures, Bossa Invest, Creative Destruction Lab +2 | 51 to 100 | 2018 |
| Muse | Muse develops brainwave-controlled computing technology that converts brainwaves into digital signals. | Biotech | Toronto | Series C | $9.5M | 2022-08-11 | $39.9M | Felicis, Export Development Canada, OMERS Ventures +2 | 11 to 50 | 2007 |
| Nicoya Lifesciences | Nicoya is a nanotechnology company that develops sensor products. | Biotech | Waterloo | Series A | $15.6M | 2021-12-16 | BDC Venture Capital, Export Development Canada, Accelerator Centre | 51 to 100 | 2012 | |
| Winterlight Labs | Winterlight Labs builds technology that detects signs of cognitive impairment from speech samples. | Artificial intelligence | Toronto | Series A | $4.2M | 2019-11-18 | Creative Destruction Lab, Ontario Centres of Excellence, First Star Ventures +2 | 11 to 50 | 2015 | |
| GeneYouIn | GeneYouIn is a Canadian personalized medicine company that developed Pillcheck, a genome analytics and reporting platform. | Biotech | Toronto | Angel | $150K | 2015-06-20 | $150K | Ontario Centres of Excellence | 11 to 50 | 2012 |
Table 1. Biotech startups in Canada: the 21 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 285.
Largest rounds
Last 12 months| # | Company | What they do | Sector | City | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Specific Biologics | Specific Biologics develops gene editing technologies to treat diseases at the genetic level inside the body. | Biotech | Toronto | Series A | $35.0M | 2026-11-02 | $36.3M | Creative Destruction Lab, Lumira Ventures, adMare Bio Innovations | 1 to 10 | 2017 |
| 2 | Altis Labs | Altis Labs uses AI endpoints to speed clinical trials so new treatments reach patients sooner. | Artificial intelligence | Toronto | Series A | $25.0M | 2026-09-17 | $31.0M | Creative Destruction Lab, Debiopharm Innovation Fund, Benchstrength | 11 to 50 | 2019 |
| 3 | Kainova Therapeutics | Kainova Therapeutics develops therapies that modulate GPCRs to treat immuno-oncology and inflammatory conditions. | Biotech | Montréal | Series B | $23.5M | 2026-02-09 | $123.6M | Bpifrance, Sofinnova Partners, Andera Partners +1 | 11 to 50 | 2001 |
| 4 | Future Fertility | Future Fertility provides artificial intelligence tools for reproductive medicine. | Artificial intelligence | Toronto | Series A | $4.1M | 2026-04-23 | $4.1M | M Ventures, Whitecap Venture Partners | 11 to 50 | 2018 |
| 5 | Opalia | Opalia develops cell-based food technology for producing animal-free dairy. | Biotech | Montréal | Seed | $2.3M | 2026-04-28 | $3.9M | Business Development Bank of Canada, Investissement Quebec, Cycle Momentum +2 | 1 to 10 | 2020 |
| 6 | 3D BioFibR | 3D BioFibR manufactures biopolymer fibers, yarns, and scaffolds for medical devices and regenerative medicine. | Biotech | Halifax | Seed | $100K | 2026-07-10 | $8.5M | Creative Destruction Lab, Innovacorp, Globalive +2 | 11 to 50 | 2020 |
| 7 | BryoSphere | BryoSphere manufactures specialty chemicals using moss plants and biotechnology methods. | Biotech | Burnaby | Angel | $29K | 2026-09-08 | $29K | SOSV, SOSV SF & NY (Fka IndieBio) | 1 to 10 | 2022 |
Table 2. Biotech startups in Canada: the 7 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | Creative Destruction Lab | Entrepreneurship program | Toronto, Canada | 11 | 4% | 3 | Specific Biologics, Altis Labs, 3D BioFibR |
| 2 | Export Development Canada | Government investment office | Ottawa, Canada | 4 | 1% | ||
| 3 | BDC Venture Capital | Government investment office | Calgary, Canada | 4 | 1% | ||
| 4 | Investissement Quebec | Fund of funds | Quebec, Canada | 4 | 1% | 1 | Opalia |
| 5 | Toronto Innovation Acceleration Partners | Venture capital firm | Toronto, Canada | 4 | 1% | ||
| 6 | Anges Quebec | Angel group | Quebec, Canada | 4 | 1% | ||
| 7 | BDC Capital Corporation | Venture capital firm | Wakefield, United States | 3 | 1% | ||
| 8 | Business Development Bank of Canada | Private equity firm | Montréal, Canada | 3 | 1% | 1 | Opalia |
| 9 | Alexandria Venture Investments | Venture capital firm | Pasadena, United States | 3 | 1% | ||
| 10 | Techstars | Startup accelerator | New York, United States | 3 | 1% | ||
| 11 | adMare Bio Innovations | Startup accelerator | Vancouver, Canada | 2 | 1% | 2 | Specific Biologics, Kainova Therapeutics |
| 12 | Inovia Capital | Venture capital firm | Montréal, Canada | 2 | 1% | ||
| 13 | Accelerator Centre | Startup accelerator | Waterloo, Canada | 2 | 1% | ||
| 14 | Innovacorp | Micro VC fund | Halifax, Canada | 2 | 1% | 1 | 3D BioFibR |
| 15 | Cycle Momentum | Startup accelerator | Montréal, Canada | 2 | 1% | 1 | Opalia |
Table 3. Biotech startups in Canada: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
| Sectors | Companies | Share | Total raised |
|---|---|---|---|
| Health care | 215 | 75% | $2.2B |
| Software | 48 | 17% | $440.0M |
| Artificial intelligence | 26 | 9% | $371.4M |
| Hardware | 16 | 6% | $45.1M |
| Energy | 5 | 2% | |
| Education | 3 | 1% | $2.2M |
| Cybersecurity | 2 | 1% | |
| Fintech | 2 | 1% | $150K |
Table 4. Biotech startups in Canada by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
Table 5. Biotech startups in Canada by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Cities
Table 6. Biotech startups in Canada by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| November 2026 | 2 | 7% | $56.5M |
| October 2026 | 1 | 4% | $5.8M |
| September 2026 | 4 | 14% | $27.9M |
| July 2026 | 4 | 14% | $1.1M |
| June 2026 | 2 | 7% | $225K |
| May 2026 | 4 | 14% | $15.4M |
| April 2026 | 3 | 11% | $11.3M |
| March 2026 | 2 | 7% | $73K |
| February 2026 | 1 | 4% | $23.5M |
| January 2026 | 2 | 7% | $7.4M |
| December 2025 | 2 | 7% | $12.0M |
| November 2025 | 1 | 4% |
Table 7. Biotech startups in Canada: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 25 | 9% | $149.2M |
| 2025 | 21 | 7% | $230.8M |
| 2024 | 26 | 9% | $434.7M |
| 2023 | 16 | 6% | $273.5M |
| 2022 | 29 | 10% | $155.1M |
| 2021 | 22 | 8% | $385.5M |
Table 8. Biotech startups in Canada by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2023 or later | 20 | 7% |
| 2020 to 2022 | 53 | 19% |
| 2015 to 2019 | 112 | 40% |
| 2010 to 2014 | 49 | 18% |
| Before 2010 | 45 | 16% |
Table 9. Biotech startups in Canada by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 163 | 59% |
| 11 to 50 | 94 | 34% |
| 51 to 100 | 13 | 5% |
| 101 to 250 | 4 | 1% |
| 251 to 500 | 1 | 0% |
| 501 to 1,000 | 1 | 0% |
| 5,001 to 10,000 | 1 | 0% |
Table 10. Biotech startups in Canada by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when Biotech is one of its sectors and its headquarters is in Canada. On 16 November 2026 that is 285 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 21 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 285 rows: 92 have no round amount, 0 no city and 134 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many biotech startups in Canada are on the list?
- 285, in the file dated 16 November 2026. 28 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 285 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.